Treatment of acute coronary syndrome with glp-1

Details for Australian Patent Application No. 2001263230 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Ehlers, Mario; Coolidge, Thomas R.

Agent Davies Collison Cave

Pub. Number AU-B-2001263230

PCT Pub. Number WO01/89554

Priority 60205239 19.05.00 US

Filing date 18 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 10 March 2005

International Classifications

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

12 February 2004 Assignment before Grant

  Bionebraska, Inc. The application has been assigned to Amylin Pharmaceuticals, Inc.

10 March 2005 Application Accepted

  Published as AU-B-2001263230

7 July 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001263231

2001263229